Table 2: Mean Value of Original scores of IgG, kappa and lambda, and Current Reading of 3 markers over Time in group A (FSGS) and group B cases (immune complex mediated glomerulopathy [ICMG])
|
Control
A
|
ICMGN, B1 |
ICMGN, B2 |
ICMGN, B3 |
n |
21 |
12 |
10 |
13 |
Original Staining
IgG
|
0.05 ± 0.05 |
2.83 ± 0.12 |
3.00 ± 0.00 |
2.77 ± 0.12 |
Original Staining
kappa
|
0 ± 0 |
2.16 ± 0.21 |
2.50 ± 0.22 |
2.39 ± 0.18 |
Original Staining
lambda
|
0 ± 0 |
1.91 ± 0.23 |
2.10 ± 0.23 |
2.54 ± 0.14 |
1st F-U months |
12-18 |
12 -18 |
6-11 |
1-5 |
1st F-U IgG |
0.03 ± 0.03 |
2.50 ± 0.20 |
2.20 ± 0.15 |
2.69 ± 0.13 |
1st F-U Kappa |
0 ± 0 |
2.08 ± 0.19 |
2.00 ± 0.21 |
2.46 ± 0.18 |
1st F-U Lambda |
0 ± 0 |
1.67 ± 0.14 |
2.00 ± 0.21 |
2.46 ± 0.14 |
2nd F-U months |
53-58 |
53-58 |
46-52 |
40-45 |
2nd F-U IgG |
0 ± 0 |
1.09 ± 0.09*# |
1.09 ± 0.09*# |
1.50 ± 0.23*# |
2nd F-U Kappa |
0 ± 0 |
0.64 ± 0.15*# |
0.67 ± 0.14*# |
1.09 ± 0.23*# |
2nd F-U lambda |
0 ± 0 |
0.64 ± 0.15*# |
0.50 ± 0.15*# |
1.33 ± 0.19*# |
* vs Original and # vs 1st follow-up (F-U),P value<0.05=significance. B1 - Subgroup of B with the first follow-up at 12 - 18 months and the second follow-up at 53 - 58 months, B2 with the first follow-up at 6 - 11 months and the second follow-up at 53 - 58 months, and B3 with the first follow-up at 1 - 5 months and the second follow-up at 40 - 45 months.